ANVISA approves first tetrahydrocurcuminoid for use in Brazil
Natural ingredient supplier Sabinsa announced this week that The Brazilian Health Regulatory Agency (ANVISA) has green-lighted its Curcumin C3 Reduct as health ingredient in the country.
Archives for January 19, 2024
Timeline raises CHF 56M from L’Oréal and Nestlé in Series D financing
Swiss longevity biotech company Timeline (parent company Amazentis) announced that it has raised CHF 56 million (US$ 66 million) in an oversubscribed Series D financing round that included strategic investments by L’Oréal and Nestlé.